Nebraska Medicine CEO salary and executive pay
Nebraska Medicine paid its CEO, James Linder MD, $2,775,089 for the fiscal year ending June 2025. That is up $61,005 (2.2%) from the fiscal year ending June 2024. Total revenue on that return was $2,799,901,402, up 21.5% from $2,303,519,624 for the fiscal year ending June 2024. Nebraska Medicine ranks 127th of 229 hospital systems on this site by CEO pay. Nebraska Medicine has 4 Form 990 returns on record, for fiscal years ending 2022 to 2025.
Last updated from IRS e-file data. EIN 91-1858433, Omaha, NE.
CEO, fiscal year ending June 2025
$2,775,089
Also listed with a chief executive title on this filing: Michael A Ash MD (President & COO), $1,319,800.
- Total revenue
- $2,799,901,402
- CEO pay vs. peers
- Higher than 27%
Source: Form 990, fiscal year ending June 2025, IRS object ID 202641349349302129.View the filing
Peers: the 183 other hospital systems on this site. Ranked 133rd of 184 by top pay as a share of revenue. Pay is 0.10% of revenue, our calculation from the same return. Revenue is Part I, line 12; peers are compared on their latest full-year returns.
Highest-paid people on the latest return
On the latest return, 16 people were paid more than $500,000, 5 of them more than $1 million.
| Name and title | Total |
|---|---|
| James Linder MD CEO Chairman & CEO | $2,775,089 |
| Michael A Ash MDPresident & COO | $1,319,800 |
| Stephanie DaubertCFO | $1,106,683 |
| Harris A Frankel MDChief Medical Officer | $1,090,112 |
| Anna L CramerChief Legal Officer & Chief People Officer | $1,022,859 |
Also paid on the latest return: Suzanne Nuss PHD (Clinical Workforce Development Officer), $908,039; David W Mercer MD (Director), $748,368; Steven J Lisco MD (Chief Academic Officer), $684,434; Scott Raymond (Information Technology VP (THRU 06/2025)), $629,709; Kyle Skiermont PharmD (SVP of Operations), $621,658; Frank Venuto (Chief Human Capital Officer), $607,752; Kelly Vaughn (Chief Nursing Officer), $578,295; Debra Romberger MD (Director (THRU 05/2025)), $576,957; Matthew E Pospisil (Periop Svs/Bellevue VP), $569,975; Thomas C Macy (Amb Clinics/Clinical Prog VP), $569,575; Julie Lazure (Acute Care/Path Svcs VP), $550,130; Tammy Winterboer PharmD (Quality, Effectiveness, & Exp VP), $470,082; Jennifer L Brown MD (Staff Physician-Primary), $463,101; Isaac J Berg MD (Staff Physician-Primary), $462,789; Jennifer Bartholomew (Facilities Management VP), $460,469; and 2 more.
Also listed in Part VII of the latest return, with no pay reported: Bruce Grewcock (Director (Treasurer)), Mogens Bay (Director (Vice Chairman)), Nancy Keegan (Director (Secretary)), Eric K Keen (Director), H Dele Davies MD (Director), James T Canedy MD (Director), Jane Miller (Director), Lance M Fritz (Director).
CEO pay by year
Each row is the CEO on that year's return.
| Fiscal year ending | Name and title | Total | Revenue | Source |
|---|---|---|---|---|
| Jun 2025 | James Linder MD CEO Chairman & CEO | $2,775,089 | $2,799,901,402 | Filing |
| Jun 2024 | James Linder MD CEO CEO | $2,714,084 | $2,303,519,624 | Filing |
| Jun 2023 | James Linder CEO CEO | $2,564,504 | $2,083,654,888 | Filing |
| Jun 2022 | James Linder CEO CEO | $3,563,233 | $1,855,915,359 | Filing |
How this pay was reported
The parts of each total, as reported on the return for the fiscal year ending June 2025.
Source: Form 990, fiscal year ending June 2025, IRS object ID 202641349349302129.View the filing
| Part VII | Schedule J | |||||||
|---|---|---|---|---|---|---|---|---|
| Name and title | From org | Other | Base | Bonus | Other | Deferred | Nontaxable | Total |
| James Linder MDChairman & CEO | $2,757,951 | $17,138 | $1,648,965 | $776,581 | $332,405 | $10,350 | $6,788 | $2,775,089 |
| Michael A Ash MDPresident & COO | $1,279,745 | $40,055 | $917,221 | $339,524 | $23,000 | $27,600 | $12,455 | $1,319,800 |
| Stephanie DaubertCFO | $1,072,132 | $34,551 | $763,876 | $282,276 | $25,980 | $27,600 | $6,951 | $1,106,683 |
| Harris A Frankel MDChief Medical Officer | $1,061,064 | $29,048 | $675,596 | $273,173 | $112,295 | $27,600 | $1,448 | $1,090,112 |
| Anna L CramerChief Legal Officer & Chief People Officer | $998,446 | $24,413 | $724,840 | $249,433 | $24,173 | $23,288 | $1,125 | $1,022,859 |
These figures come from Nebraska Medicine's Form 990 returns, as the IRS publishes them. The methodology page explains how they're chosen. To report an error, email corrections@ceopaycheck.com.
How Nebraska Medicine compares
Ranked 127th of 229 hospital systems by CEO pay.
- Previous in this ranking: 126th, Legacy Health, $2,784,747
- Next in this ranking: 128th, Sharp HealthCare, $2,750,617
Closest in revenue among the hospital systems on this site:
Children's Healthcare of Atlanta$3,008,349 (CEO), fiscal year ending Dec 2024
Rush University System for Health$4,819,778 (CEO), fiscal year ending Jun 2025
Stanford Medicine Children's Health$2,338,281 (CEO), fiscal year ending Aug 2025
Presbyterian Healthcare Services$4,407,510 (CEO), fiscal year ending Dec 2024
UC Health (Cincinnati)$2,068,092 (CEO), fiscal year ending Jun 2025
Common questions
James Linder MD (Chairman & CEO) was paid $2,775,089 for the fiscal year ending June 2025: $2,757,951 from Nebraska Medicine and $17,138 in other compensation (Part VII columns D and F).
The CEO, James Linder MD, was the highest-paid person on the latest return, at $2,775,089.
Nebraska Medicine paid its CEO, James Linder MD, $2,775,089 for the fiscal year ending June 2025. That is up $61,005 (2.2%) from the fiscal year ending June 2024. The earliest return on record is for the fiscal year ending June 2022, when the CEO was James Linder, paid $3,563,233. By fiscal year end: June 2022, $3,563,233 (James Linder); June 2023, $2,564,504; June 2024, $2,714,084; June 2025, $2,775,089.
Nebraska Medicine's return for the fiscal year ending June 2025 reports total expenses of $2,523,478,632 and total revenue of $2,799,901,402 (Part I, lines 18 and 12), so revenue exceeded expenses by $276,422,770. Expenses were $2,175,372,006 for the fiscal year ending June 2024, so they rose 16.0%. The CEO's pay of $2,775,089 equals 0.11% of expenses, our calculation.
From the 4 Form 990 returns Nebraska Medicine filed with the IRS for fiscal years ending 2022 to 2025. The latest full-year return was filed on May 14, 2026. Schedule J of the fiscal year ending June 2025 return breaks down pay for all 5 people in the pay breakdown above.